Form 8-K - Current report:
SEC Accession No. 0001104659-26-036201
Filing Date
2026-03-27
Accepted
2026-03-27 16:54:45
Documents
12
Period of Report
2026-03-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mxct-20260323x8k.htm   iXBRL 8-K 44951
2 EX-99.1 mxct-20260323xex99d1.htm EX-99.1 7606
  Complete submission text file 0001104659-26-036201.txt   172272

Data Files

Seq Description Document Type Size
3 EX-101.SCH mxct-20260323.xsd EX-101.SCH 2676
4 EX-101.LAB mxct-20260323_lab.xml EX-101.LAB 16575
5 EX-101.PRE mxct-20260323_pre.xml EX-101.PRE 10714
15 EXTRACTED XBRL INSTANCE DOCUMENT mxct-20260323x8k_htm.xml XML 5020
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40674 | Film No.: 26808234
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)